FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor- , ameliorates endotoxin-induced shock

By Yamamoto N.   Sakai F.   Yamazaki H.   Sato N.   Nakahara K.   Okuhara M.  

European Journal of Pharmacology, Vol. 327, Iss. 2, 1997-05 ,pp. : 169-174

Elsevier

Access to resources Recommend Favorite

Pirfenidone suppresses tumor necrosis factor- , enhances interleukin-10 and protects mice from endotoxic shock

By Oku H.   Nakazato H.   Horikawa T.   Tsuruta Y.   Suzuki R.  

European Journal of Pharmacology, Vol. 446, Iss. 1, 2002-06 ,pp. : 167-176

Elsevier

Access to resources Recommend Favorite

Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice

By Di Santo E.   Adami M.   Bertorelli R.   Ghezzi P.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 197-202

Elsevier

Access to resources Recommend Favorite

Tumor necrosis factor- prevents interleukin-1 from augmenting capsaicin-induced vasodilatation in the rat skin

By Herbert M.K.   Hering S.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 273-279

Elsevier

Access to resources Recommend Favorite

Tumor necrosis factor measurement and use of different anticoagulants: Possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes

By Hoffmann J. N.   Hartl W. H.   Faist E.   Jochum M.   Inthorn D.  

Inflammation Research, Vol. 46, Iss. 9, 1997-09 ,pp. : 342-347

Springer Publishing Company

Access to resources Recommend Favorite